IRWD - PRICE - Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (IRWD) has minimized production risks by outsourcing drug manufacturing to third-party facilities, as evidenced by the shares with the 4.09 metric on this price chart. Revenues are based on the sales of a patent-protected flagship gastrointestinal therapy. Simultaneously, the company is increasing its capital by acquiring promising molecules and small startups to diversify its medical portfolio.

Price represents the market equivalent of a business stake's value, determined by the balance of supply and demand, which allows for the comparison of real capitalization with consensus forecasts via the current share price. This indicator measures market sentiment, which for Ironwood Pharmaceuticals (IRWD) is particularly sensitive to external supply chain risks and dependence on third-party manufacturing sites.